Skip to content
Men Under Microscope – Lifestyle
Author:
Thalia Therapeutics PLC
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
November 16, 2026
Thalia Therapeutics PLC Announces Acquisition and £2.75 Million Fundraise
June 24, 2026